Russia is expected to register its second potential vaccine against coronavirus COVID-19 by October 15.
The vaccine has been developed by Siberia’s Vector Institute, which completed early-stage human trials of the vaccine last week.
Russia registered its first vaccine candidate, developed by Moscow’s Gamaleya Institute, in August.
